URGN - UroGen Pharma commences public offering of ordinary shares
2024-06-17 17:10:59 ET
More on UroGen Pharma
- UroGen: Q3 NDA Opens Hefty Revenue Opportunity
- UroGen Pharma Ltd. (URGN) Q1 2024 Earnings Call Transcript
- UroGen surges on updated late-stage data for bladder cancer therapy
- Urogen files patent suit against Teva over cancer therapy
- Seeking Alpha’s Quant Rating on UroGen Pharma